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Recent evidence suggests that adult-derived stem
cells, like their embryonic counterparts, are pluripo-
tent. These simple, undifferentiated and uncommit-
ted cells are able to respond to signals from their host
tissue microenvironment and differentiate, produc-
ing progeny that display a phenotype characteristic
of the mature cells of that tissue. We used a clonal
stem cell line (termed WB-F344) that was derived
from an adult male rat liver to investigate the possi-
bility that uncommitted stem cells from a nonmyo-
genic tissue source would respond to the tissue mi-
croenvironment of the heart in vivo and differentiate
into cardiac myocytes. Male WB-F344 cells that carry
the Escherichia coli b-galactosidase gene were iden-
tified in the left ventricular myocardium of adult fe-
male nude mice 6 weeks after transplantation. We
confirmed the presence of a rat Y-chromosome-spe-
cific repetitive DNA sequence exclusively in the b-ga-
lactosidase-positive myocytes by polymerase chain
reaction and fluorescence in situ hybridization. Im-
munohistochemistry, using a cardiac troponin T-spe-
cific monoclonal antibody, and ultrastructural analy-
sis confirmed a cardiac myocyte phenotype of the
stem cell-derived myocytes. The b-galactosidase-posi-
tive myocytes ranged from <20 mm to 110 mm in
length. The longer of these cells contained well-orga-
nized sarcomeres and myofibrils, and formed inter-
calated disks and gap junctions with endogenous
(host-derived) myocytes, suggesting that WB-F344-de-
rived myocytes participate in the function of the car-
diac syncytium. These results demonstrate that adult
liver-derived stem cells respond to the tissue micro-
environment of the adult heart in vivo and differen-
tiate into mature cardiac myocytes. (Am J Pathol
2001, 158:1929–1935)
Recent studies have emphasized the dominance of the
tissue microenvironment on the differentiation and func-
tional properties of stem cells after their transplantation
and engraftment.1–16 Embryonic stem cells that home in
a microenvironment have been shown to respond to cues
in the surrounding niche and to acquire the phenotypic
characteristics of cells native to that tissue microenviron-
ment. Several lines of evidence suggest that adult-de-
rived stem cells, like their embryonic counterparts, pos-
sess multipotent differentiation capacity.1–6 Neural stem
cells derived from adult donors differentiate into a hema-
topoietic lineage when engrafted into bone marrow.4,9
Adult-derived bone marrow stem cells differentiate in vivo
into neural5,7,10,15,16, skeletal muscle,11,12 and hepatic
cells13,14 after their transplantation and engraftment into
these tissue sites. The results from these studies suggest
that undifferentiated stem cells derived from adult tissues
are not determined progenitor cells with limited differen-
tiation potential. Rather, these cells seem to possess a
much broader capacity for cellular differentiation that is
dependent on and responsive to the specific signals
present in the microenvironment of the transplantation
site. That adult-derived stem cells possess this form of
reactive plasticity of differentiation capacity raises the
intriguing possibility that stem cells isolated from extra-
cardiac tissue in a patient could be used to repair the
damaged heart of the same patient.
We tested the concept that adult-derived stem cells
will differentiate into cardiac myocytes in the tissue mi-
croenvironment of the heart in vivo using a clonal stem
cell line (WB-F344) derived from the adult liver.17–22 The
WB-F344 cell line was isolated and cloned from the liver
of a young adult male Fischer 344 rat and established as
a propagable cell line under conditions that excluded
differentiated hepatocytes or biliary epithelial cells as the
cells of origin.17–22 WB-F344 cells are diploid, anchor-
age-dependent, express contact inhibition in vitro, and
Supported in part by National Heart, Lung, and Blood Institute grants R01
HL42250, R01 HL20749, and R01 CA29323 from the National Cancer
Institute.
Accepted for publication February 16, 2001.
Address reprint requests to Nadia N. Malouf, M.D., Department of
Pathology, University of North Carolina at Chapel Hill, CB 7525, Brinkhous
Bullitt Bldg., Chapel Hill, NC 27514. E-mail: malouf@med.unc.edu.
American Journal of Pathology, Vol. 158, No. 6, June 2001
Copyright © American Society for Investigative Pathology
1929
are not tumorigenic. They exhibit a poorly differentiated
nonhepatocytic simplified epithelial cell phenotype in
vitro. After exposure to differentiating stimuli in vitro, WB-
F344 cells express phenotypes with characteristics of
hepatocytes.20 Most important, in the context of the
present study, WB-F344 cells transplanted into synge-
neic rat liver give rise to differentiated hepatocytes and
biliary epithelial cells in vivo.21,22,23 We transplanted WB-
F344 cells into normal hearts of adult female nude mice to
examine the engraftment and differentiation potential of
this male adult-derived stem cell line in the cardiac mi-
croenvironment in vivo. We present evidence that the
liver-derived WB-F344 stem cells modulate their lineage
commitment after transplantation into the cardiac tissue
microenvironment in the adult heart and differentiate into
cardiac myocytes in vivo.
Materials and Methods
Cell Culture and Transplantation
Male WB-F344 cells were genetically tagged with the E. coli
lac Z gene (b-galactosidase) by infection with the CRE
BAG2 retrovirus.21 WB-F344 cells were cultured in Richter’s
minimal essential medium supplemented with 10% fetal calf
serum, in a 5% CO2, 95% air environment, at 37°C. Cells
intended for transplantation were harvested by trypsiniza-
tion, washed in cell culture medium, and resuspended in
serum-free medium at 2 3 105 cells/ml. Female homozy-
gote nude mice (Tac:Cr:(NCr)-nufBR) were anesthetized
with ketamine (50 mg/kg) and xylazine (2.5 mg/kg) injected
intraperitoneally. Cell injections were performed with the
needle attached directly to a tuberculin syringe or a butterfly
infusion system and introduced over the subxyphoid area
and directed cephalad toward the left lateral chest. When
blood was aspirated from the left ventricle, the cells (50 ml of
2 3 105 cells/ml) were injected, presumably in the wall of
the ventricle, as the needle was withdrawn. Control animals
were handled identically, and received sham injections of
serum-free medium. The mice were euthanized 6 weeks
later by inhalation of isofluorane. National Institutes of Health
guidelines for the usage of laboratory animals were strictly
followed. The experimental protocol was approved by the
Duke Institutional Animal Care and Use Committee.
Histochemistry and Immunohistochemistry
The hearts were dissected and sliced coronally into three
blocks, which were immediately frozen in liquid nitrogen,
and stored at 280°C. Five serial cryostat sections (8 mm)
were obtained from each block and used to screen for
b-galactosidase activity, using a b-galactosidase-stain-
ing kit from Boehringer Mannheim (Mannheim, Germany).
For the b-galactosidase reaction, cryosections on glass
slides were fixed for 10 minutes in 2% formaldehyde
(Mallinckrodt, Paris, Kentucky), 0.2% glutaraldehyde
(Fisher, Pittsburgh, PA), in 0.1 mol/L sodium phosphate
buffer, pH 7.3. The sections were then extensively
washed in this buffer and incubated at 37°C with the
b-galactosidase substrate, 3-indolyl-b-D-galactopyrano-
side (X-gal; Boehringer Mannheim, Mannheim, Germany)
for 1 to 4 hours. If b-galactosidase-positive cells were not
found on the initial screen, the heart blocks were not
sectioned further. Blocks that contained b-galactosidase-
expressing cells were selected and serially sectioned
obtaining 70 serial 8-mm sections. These sections were
kept at 280°C until needed. The b-galactosidase ex-
pressed in the cytoplasm of WB-F344 cells is bacterial in
origin and is optimally activated at pH 7 to 7.5, whereas
mammalian (lysosomal) b-galactosidase is activated at
lower pH (pH 3.0 to 6.0). We monitored the pH of all
solutions used in the b-galactosidase reactions and
strictly maintained the pH at 7.3. This rigorous control of
the pH enhanced the possibility that only bacterial b-ga-
lactosidase activity was detected.
Demonstration of cardiac troponin T was achieved
using a monoclonal antibody (mAb) (designated mAb
13-11) that recognizes a cardiac-specific troponin T
epitope.24 For this purpose, frozen tissue sections were
fixed in 1% formaldehyde in phosphate-buffered saline
permeabilized with 0.1% Triton, and incubated with mAb
13-11, as previously described.25 A goat fluorescein-
labeled anti-mouse antibody was used as a secondary
antibody. Normal mouse serum was substituted for the
primary antibody in control immunostaining reactions.
Electron Microscopy
Fresh frozen heart muscle sections were fixed in 1%
formaldehyde while still adherent on the glass slides as
described above for the b-galactosidase reaction. After
performing the b-galactosidase reaction, the sections
were postfixed in 1% osmium tetraoxide, dehydrated in a
graded ethanol series, and infiltrated in L. R. White resin
(Ted Pella, Redding, CA). After separating the glass from
the resin, b-galactosidase-positive myocytes were se-
lected and microsectioned at 70 nm. The thin sections
were examined with a LEO EM 910 transmission electron
microscope at 80 kV. No lead citrate or uranyl acetate
was used for postfixation or counterstaining.
Laser Capture Microdissection (LCM)
After performing the b-galactosidase reaction, tissue
sections were washed in phosphate-buffered saline and
dehydrated according to the National Institutes of Health
protocol for LCM (Ref 26; http://dir.nichd.nih.gov/1 cm/
LCMTAP.htm). Single b-galactosidase-expressing myo-
cytes and endogenous (host) myocytes were indepen-
dently microdissected from recipient heart sections using
an Arcturus Pixcell II laser capture microdissection instru-
ment and the instructions supplied with the instrument.
Four WB-F344-derived b-galactosidase-positive myo-
cytes were captured on one cap membrane and two cells
on another (Figure 1, c and d). Twenty myocytes that did
not express b-galactosidase (host myocytes) were cap-
tured on a third membrane. The caps were inserted into
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Eppendorf tubes containing 50 ml of a digestion buffer
suggested by the National Institutes of Health protocol
(0.04% proteinase K, 1 mmol/L ethylenediaminetet-
raacetic acid, 10 mmol/L Tris-HCl, pH 8.0, and 1%
Tween-20). The digestion was allowed to continue over-
night at 37°C. The resulting nucleic acid fraction served
as a template for amplification of a rat Y-chromosome-
specific repetitive DNA sequence using primers previ-
ously described:27 59-GGTTCTAGACTGTAAAACCCA-
GAC-39 and 59-ACTTAAAACTAAGCTTATTGGCCA-39. A
portion (10 ml) of the polymerase chain reaction (PCR)
reactions were analyzed on 1.5% agarose gels (Figure 1e)
and the remaining PCR product was cloned into a TA
cloning vector (InVitrogen, Carlsbad, CA). The resulting
clones were screened for the Y-chromosome-specific re-
petitive DNA sequence by PCR, and subsequently, positive
clones were subjected to automated DNA sequencing.
Fluorescence in Situ Hybridization (FISH)
The FISH reaction was performed on fresh-frozen 8-mm
tissue sections that immediately preceded or followed a
section that demonstrated b-galactosidase-expressing
myocytes. A rat Y-probe,27 consisting of a Y-chromosome-
specific repetitive DNA sequence in pUC18 plasmid
(kindly provided to us by Dr. Barbara Hoebee, Bilthoven,
The Netherlands) was used to test whether the b-galac-
tosidase-expressing cells originated from the trans-
planted WB-F344 cells. The Y-probe-containing plasmid
was labeled with digoxigenin by nick translation (Boehr-
inger Mannheim). FISH was performed on fresh frozen
tissue sections fixed in 1:1 (v/v) acetone-methanol solu-
tion. DNA was denatured in a solution of 70% formamide
(Omnipur, Gibbstown, NJ) in 23 standard saline citrate
(0.3 mol/L NaCl, 30 mmol/L sodium citrate) at 70°C for 12
minutes.28 The probe was denatured at 72°C and applied
to the tissue section overnight at 37°C in a humidified
chamber. The sections were washed three times for 10
minutes each in 50% formamide in 23 standard saline
citrate solution at 42°C, followed by two washes in 23
standard saline citrate for 5 minutes each and incubated
with a sheep anti-digoxigenin-rhodamine-labeled anti-
body (Roche, Indianapolis, IN). After this incubation, the
slides were washed, covered using a mounting medium
containing 4,6-diamidino-2-phenylindole counter stain
(Vectashield; Vector Laboratories, Inc., Burlingame, CA),
and examined using a Zeiss confocal fluorescence mi-
croscope equipped with a triple-band pass filter.
Results
WB-F344-derived myocytes were found engrafted in the
myocardium of host mice 6 weeks after cardiac injection.
WB-F344-derived myocytes were identified among host
myocytes based on their expression of histochemically
detectable b-galactosidase activity (Figures 1 and 2).
WB-F344-derived myocytes were found on the initial
screen in the left ventricular myocardium of two mice.
Hearts from the other eight mice did not demonstrate
b-galactosidase-expressing cells on the initial screen
and were not sectioned further. It is conceivable that in
these mice the injected cells entered the left ventricle and
became scattered throughout the systemic circulation.
Alternately, b-galactosidase-positive myocytes might be
present within aspects of the heart tissues that were not
sectioned and analyzed in the present study. Future stud-
ies will examine these possibilities. b-galactosidase ex-
pression was confirmed to originate exclusively from en-
grafted WB-F344 cells in the two mice with the following
experiments. We monitored the timing for development of
the blue precipitate during incubation with the X-gal sub-
strate and found the blue color developed within the first
1 to 2 hours of incubation. We allowed the incubation to
continue for an additional 2 to 3 hours for easier visual-
ization by light microscopy. Taking advantage of the male
origin of WB-F344 cells engrafted into female recipient
hosts, we confirmed that the b-galactosidase expressing
cells had a rat Y-chromosome-specific DNA sequence.
Figure 1. WB-F344 cells engraft in the myocardium. Engrafted WB-F344 cells
express b-galactosidase (a–c) and range from small undifferentiated cells to
long striated cells that measure up to 110 mm in length (b). b-galactosidase-
expressing myocytes before dissection by LCM (c, asterisks) and after (d,
asterisks) were used as a template to amplify by PCR a rat Y-chromosome-
specific repetitive DNA sequence. e: Agarose electrophoresis of the PCR
product. Unlike myocytes from control female mice (lane 5) but like WB-
F344 cells grown in culture (lane 2), b-galactosidase-expressing myocytes
(lanes 1 and 3) contain multimeters of the rat Y-chromosome repetitive
200-bp sequence (200, 400, 600 bp). e: lane 1, PCR product from four blue
WB-F344-derived myocytes dissected by LCM from a female mouse donor
heart section; lane 2, PCR product from WB-F344 cells in culture; lane 3,
PCR product from two blue WB-F344-derived myocytes dissected by LCM
from a female mouse donor heart section; lane 4, molecular weight standard
(New England Biolabs, Beverly, MA); lane 5, PCR product from 20 random
control native myocytes. f: A b-galactosidase-expressing myocyte demon-
strates, after permeabilization and incubation with mAb 13-11, fluorescent
sarcomeric striations (g, arrow) in the same cell. Scale bar, 25 mm.
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Additionally, we ruled out the possibility that b-galactosi-
dase activity might have originated from endogenous
inflammatory cells, such as macrophages, which could
have invaded the myocardium in response to the injec-
tion of WB-F344 cells. We elicited a cellular inflammatory
response in a control mouse by injecting thioglycollate in
the peritoneal cavity and examined the inflammatory cells
for b-galactosidase activity. Although the inflammatory
response was intense, no cells demonstrated b-galacto-
sidase activity. Collectively, these results lead us to con-
clude that the b-galactosidase-positive myocytes in the
recipient hearts originated from the engrafted donor WB-
F344 stem cells.
The number of b-galactosidase-positive cells con-
tained within an individual tissue section varied through-
out the heart wall. b-galactosidase-positive cells present
in one section would disappear with further serial sec-
tioning and reappear 10 to 15 sections deeper into the
block. These findings could have resulted from WB-F344
cells being showered throughout the myocardium by way
of the coronary circulation when they were injected into
the ventricular cavity, or the cells not being continuously
injected into the myocardium, while the needle was being
withdrawn. We confirmed that b-galactosidase-express-
ing myocytes were derived from WB-F344 cells by dem-
onstrating that they contain a rat Y-chromosome through
PCR and FISH analyses of a rat Y-chromosome-specific
repetitive DNA sequence. Individual b-galactosidase-
positive myocytes were microdissected from heart cryo-
sections using laser capture microscopy (Figure 1, c and
d). PCR amplification of their DNA, cloning, and sequenc-
ing of the PCR product confirmed that the b-galactosi-
dase-positive myocytes contained the rat Y-chromo-
some-specific repetitive DNA sequence (Figure 1e). As a
positive control, we harvested WB-F344 cells from culture
and demonstrated that they contained this sequence
(Figure 1e, lane 2). In contrast, endogenous (female)
myocytes that were microdissected from tissue sites
proximal to the b-galactosidase-positive myocytes did
not contain the rat Y-chromosome-specific sequence
(Figure 1e, lane 5). We used FISH to show that b-galac-
tosidase-positive myocytes contained the rat Y-chromo-
some. The FISH reaction was performed on fresh frozen
sections while the b-galactosidase reaction was per-
formed on fixed tissue sections. To circumvent these
differences in tissue preparation, we used tissue ob-
tained from immediately adjacent 8-mm-thick serial sec-
tions, causing a shift in register of 8 mm or more. Using
this serial section approach, the cytoplasmic b-galacto-
sidase reaction product was demonstrated in one tissue
section, and the rhodamine-stained Y-chromosome in the
nucleus of the same myocyte in the adjacent section (see
Figure 3). A cardiac phenotype was confirmed in b-galac-
tosidase-expressing cells demonstrating that they ex-
pressed a cardiac-specific protein, using a monoclonal an-
tibody that recognizes a cardiac-specific troponin T
epitope, which is conserved across species.24 The b-ga-
lactosidase-expressing cells demonstrated localization
of the fluorescence to striations consistent with troponin T
localization in the sarcomere (Figure 1, f and g).
WB-F344-derived myocytes ranged from ,20 to 110
mm in length (Figure 1; a, b, c, and f). To provide a
measure of the size range among the engrafted WB-F344
cells, we grouped the cells into three sizes, ,20 mm, 20
to 50 mm, and 50 to 110 mm in length. We counted 44
cells that were ,20 mm in length, 34 cells that were 20 to
50 mm in length, and 53 cells that were 50 to 110 mm in
length. Some of the shortest cells may have been cap-
tured in cross-section. This distribution is consistent with
the possibility that WB-F344-derived cells were at differ-
ent stages of maturation 6 weeks after injection, as sug-
gested by the electron microscopic findings (Figure 1c).
The longest of the b-galactosidase-positive cells were
well differentiated with clear sarcomere striations (Figure
1b) identified by light microscopy, whereas cells that
measured 20 to 50 mm in length were less well differen-
tiated, exhibiting less well-developed sarcomeres by light
microscopy. Striations and sarcomeres in the latter group
Figure 2. Electron micrographs of b-galactosidase-expressing WB-F344-de-
rived myocytes. X-gal reaction product is the electron-dense crystalloid
precipitate in the cytoplasm of well-differentiated (A) and differentiating (C)
WB-F344-derived myocytes. A well-differentiated WB-F344-derived myocyte
with well-ordered sarcomeres is anatomically coupled via an intercalated
disk (magnified in B) and gap junctions (B, arrow) with an adjacent myo-
cyte that does not contain X-gal product. C: Nascent early sarcomere stria-
tions present in a differentiating ;20-mm myocyte (arrows, Z-band). B:
High-power of intercalated disk seen in A. Arrow points to suspected gap
junction. No counter fixation or staining with lead citrate and uranyl acetate.
Scale bars: 4 mm (A); 2 mm (B and C).
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of cells were readily demonstrated by electron micros-
copy. WB-F344-derived myocytes were identified by the
presence of the electron-dense crystalloid precipitates
(b-galactosidase reaction product) in their cytoplasm
(Figure 2). Nascent striations were present in the small
(;20 mm, Figure 2c) cells whereas larger cells demon-
strated well-organized and differentiated sarcomeres
(Figure 2a). In the well-differentiated myocytes, interca-
lated disks and apparent gap junctions formed anatom-
ical couplings between b-galactosidase-positive WB-
F344-derived myocytes and endogenous (host)
myocytes that did not contain any X-gal reaction precip-
itate (Figure 2, a and b). The presence of anatomical
couplings between stem cell-derived and host myocytes
suggests strongly that these WB-F344-derived myocytes
participate in the function of the cardiac syncytium.
Discussion
The goal of this study was to test whether the microenvi-
ronment of the heart can induce the differentiation of stem
cells derived from the liver of an adult rat into a well-
differentiated cardiac phenotype in vivo. Collectively, our
results provide proof of this concept. We demonstrate
that adult liver-derived stem cells, which differentiate into
hepatic cells in the liver in vivo, can be reprogrammed in
the heart into a cardiac lineage, producing cells with a
well-differentiated cardiac myocyte phenotype. These
findings are consistent with the hypothesis that reactiva-
tion of genetic programs in adult stem cells is possible in
response to appropriate stimulation. Although this type of
extreme reprogramming has been recently described in
somatic cells isolated from other adult tissues,29 this is
the first study to demonstrate that cells derived from an
adult liver stem cell line are capable of reprogramming
their gene expression in the adult cardiac microenviron-
ment in vivo and acquiring the phenotype of mature well-
differentiated cardiac myocytes.
It is generally believed that adult mammalian cardiac
myocytes have undergone terminal differentiation and
can no longer divide to generate new myocytes. Instead,
the residual myocytes respond to the cardiac workload
after damage by undergoing hypertrophy. Depending on
the extent and cause of injury, hypertrophied myocytes
may not successfully support the cardiac output, and
cardiac decompensation and heart failure result. The
great impact of heart disease on mortality and quality of
life and the scarcity of donor hearts for organ transplan-
tation have led several investigations to examine trans-
plantation of different types of cells into the heart in an
attempt to achieve repair.30–39 Cells used in these stud-
ies were precommitted to a muscle lineage before trans-
plantation in vivo. Embryonic cardiomyocytes derived
from embryonic stem cells39 and fetal cardiomyocytes
survive in the cardiac environment in vivo, and form prim-
itive couplings with host cells.30 Similarly, transplanted
skeletal muscle myoblasts31–37 develop into skeletal
muscle myotubes and survive uncoupled with native car-
diomyocytes for up to 3 months in recipient hearts. Car-
diac myocyte cell lines have also been generated for
potential therapeutic usage in the failing heart and for
understanding myocyte function in vitro.40,41 A cell line
derived from mouse atrial myocytes and propagated in
vitro maintained an adult cardiac myocyte phenotype in
culture.41 Bone marrow stromal cells have been trans-
formed in vitro into a cardiomyogenic cell line with 5-aza-
cytidine40 treatment. This cell line has been suggested,42
but has not been tested in vivo, as a source of cardiomy-
ocytes for cell replacement therapy in cardiomyopathies.
Our study goes further and demonstrates that cells from
Figure 3. Fluorescence in situ hybridization. The pink Y-chromosome (arrow) and the blue X-gal product are demonstrated in adjoining 8-mm serial sections
of the same cell. A: Rhodamine staining of the Y-chromosome probed with a rat Y-chromosome-specific repetitive DNA sequence (arrow). B: Adjoining section
of the same myocyte, the blue color is from the X-gal reaction. Superimposition of both signals is affected by an 8-mm shift in register of the two serial sections.
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a stem cell line that is neither of embryonic origin nor
committed to a muscle lineage will engraft in the adult
heart in vivo and differentiate into well-organized mature
cardiac myocytes.
Stem cell differentiation has been suggested to be
regulated by two independent pathways. One pathway
that allows their exit from the stem-cell state requires
negatively active events that involve the silencing of reg-
ulators that repress the expression of specific gene.43 A
second pathway that is positively acting involves regula-
tion by transcription factors that allow stem cells to enter
commitment into a specific lineage.43 The response of
this WB-F344 liver-derived stem cell line in the heart in
vivo as shown here, and a recent preliminary communi-
cation that reports that bone marrow stem cells differen-
tiate in the ischemic heart into fetal myocytes (Orlic D,
Kajstura J, Chimenti S, Li B, Anderson S, Bodine D, Pickel
J, Leri A, Nadal-Ginard B, Anversa P: Exogenous hema-
topoietic stem cells can regenerate infarcted myocar-
dium. Late Breaking Science Abstracts, American Heart
Association, 2000, New Orleans), demonstrate that the
adult heart tissue microenvironment expresses the ap-
propriate signals that allow the exit of these extracardiac
cells from their stem-cell state and differentiation into
myocytes.
This raises the possibility that adult-derived human
stem cells can be isolated from a patient, propagated in
culture, and used to support the patient’s diseased heart.
The potential therapeutic advantages of a clonal stem
cell line such as WB-F344 would be the ability to expand
the cell number in culture ex vivo and generate a well-
characterized population of cells. These could be rein-
troduced into the patient or stored for future therapeutic
interventions, avoiding the complications of allograft
transplant rejection.
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